Clinical Trial Update: Caffeine Optimization for Oxygen Saturation Index in ELBW Infants [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating caffeine citrate optimization to improve oxygen saturation in extremely low birth weight infants with neonatal apnea; r…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neonatal Apnea

Drugs mentioned

• Caffeine citrate (caffeine citrate)

Snippet

Sponsor: University of Rochester | Conditions: Neonatal Apnea, Infants | Phase 2 | Status: NOT_YET_RECRUITING